ZS Pharma, Inc. Proceeds from Convertible Debt
ZS Pharma, Inc. reported Proceeds from Convertible Debt of $5.30 million for the 12-month period ending 2012-12-31, per its 10-K filed 2015-03-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2015-03-13
- ZS Pharma, Inc. proceeds from convertible debt for fiscal 2012 was $5.30M.
| Period end | Proceeds from Convertible Debt 12 month |
|---|---|
| 2012-12-31 | $5.30M 10-K · filed 2015-03-13 |